Kinetic measurements of the fluorescent protein synthesis facilitate determination of the miRNA activity.
Philipp MalakhoviD, Yuzhe WangiD, Wenyu XueiD, Zain NofaliD, Nikolay S. IlyinskyiD, Anna V. SmirnovaiD, Roman N. Chuprov‐NetochiniD, Margarita V. PustovalovaiD, Sergey V. LeonoviD, Julian Markovich RozenbergiD
Abstract
Oncogenesis is inevitably associated with microRNA expression deregulation. Thus, development of both miRNA targeting substances or small RNA for ant-cancer therapy have been reported. Specifically, repression of the miR-16-1-3p and miR-16-2-3p activities play pivotal roles in osteosarcoma and many other cancers. The majority of miRNA sensors use protein degradation to measure miRNA activities. Here we report miRNA sensors that use fluorescent protein synthesis rather than degradation to measure miRNA activity. Specifically, miR-16-1-3p and miR-16-2-3p sensors consist of the bidirectional tet-On system driving the expression of the Katusha2S protein that is regulated by the RNA interference and GFP as a reference. These sensors specifically detect mir16-1-3p and mir16-2-3p small RNA mimics in the osteosarcoma cell line after doxycycline induction. Kinetic measurements of the reporter responses to the miRNA mimics revealed that pre-induced sensors reach significant differences from the control faster, within 2h than the sensors that were induced after mimic transfection. Thus, kinetic measurements of the fluorescent protein synthesis during doxycycline induction of the tet-On system are feasible for determination of the small RNA activity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MiR-16-1* and miR-16-2* possess strong tumor suppressive and anti-metastatic properties in osteosarcoma.
V. V. Maximov, S. Khawaled, … R. I. Aqeilan·bioRxiv·Sep 9, 2018
- Uveal Melanoma: a miR-16 disease?
A. M. Quemener, L. Bachelot, … D. Gilot·bioRxiv·Nov 30, 2021
- Targeted cancer cell killing by highly selective miRNA-triggered activation of a prokaryotic toxin-antitoxin system
Alice Turnbull, Camino Bermejo‐Rodríguez, … Guillermo de la Cueva-Méndez·ACS Synthetic BiologyPeer-reviewed·Jul 26, 2019
- Femtomolar-level PCR-free quantification of microRNA cancer biomarkers in serum
A. Kanavarioti·bioRxiv·Dec 30, 2022
- miRNA synergism impaired metabolic programming of oral cancer cells by selectively enhancing target gene specificity
Sayani Mazumder, Urbee Banerjee, … Raghunath Chatterjee·bioRxiv·Aug 1, 2024
- miRNA-34c suppresses osteosarcoma progression in vivo by targeting Notch and E2F
Y. Bae, H.-C. Zeng, … B. H. Lee·bioRxiv·May 24, 2021